Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measles Vaccine Consolidation in NSCLC
NCT00828022Phase 2Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Mar 2009
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of attenuated measles vaccine in non-small cell lung cancer (NSCLC), sponsored by Soroka University Medical Center. Status: unknown.
02
Drugs
attenuated measles vaccine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00828022.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00828022.